V
Vetphage Pharmaceuticals Private Ltd.
Proteon Pharmaceuticals serves livestock and aquaculture farms that aim for high-quality and sustainable protein production.|Proteon Pharmaceuticals modulates the microbiome to improve animal and human health. Our products allow farmers to reduce the need to use antibiotics, ...|Write to our address, contact us on the telephone or complete our contact form, we will be happy to hear from you.|Proteon Pharmaceuticals is a mission driven business that enables sustainable and economically efficient protein production.|Bacteriophage feed additive focuses on preventing and reducing the impact of bacterial infections caused by Pseudomonas and Aeromonas in pond-based aquaculture.|BAFADOR® is a cocktail of 5 virulent bacteriophages, that help fish cope with negative effects from Aeromonas and Pseudomonas bacteria. When used ahead of ...|… ... Polish biotech company Proteon Pharmaceuticals S.A, a global leader in the development and commercialization of bacteriophages for industrial use in ...|On Proteon Pharmaceuticals S.A. website we wish to provide you with the best possible access to our products and information about what we do.|Proteon Pharmaceuticals is a global leader in designing a new generation of environmentally sustainable and effective products to improve livestock farming and ...|KEY TRADE EVENTS OF THE YEAR · VIV ASIA 2023, Sustainable solutions supporting antibiotic-free animal farming by Proteon Pharmaceutical team.
Country/Area ：India
Company Email ：admin@proteonpharma.com
Industry ：Manufacturing GeneralManufacturing
Company address ：3a Ul. Tylna, Lodz, Lodz Voivodeship, 90-364, Poland
Company website ：*****
Company phone ：+48 422093395
Established ：2005
Company Revenue ：$17,662,000
Number of employees ：68
SIC Code ：28283
NAICS Code ：32325
Company News
Praca Chief Executive Officer Personal Assistant, Proteon Pharmaceuticals S.A., Łódź, Tylna 3
May 29, 2023
Oferta pracy Chief Executive Officer Personal Assistant, Proteon Pharmaceuticals S.A., Łódź, Tylna 3
May 29, 2023
Proteon Pharmaceuticals secures 21 million euro and takes another step towards sustainability in ...Aug 11, 2021
Warsaw (Poland), August 11 (ANI/BusinessWire India): Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA today announced an investment of 21 million Euro (approx. INR 200 crores) to accelerate commercialization of its products in aquaculture and livestock farming as well as to further develop its microbiome platform technology.
Aug 11, 2021Proteon Pharmaceuticals Secures 21 million Euro to Accelerate GrowthAug 10, 2021
Proteon Pharmaceuticals secures investment to accelerate commercialization of products and expansion of phage product development platform. WARSAW, POLAND, August 10, 2021 /EINPresswire.com/ -- Proteon Pharmaceuticals today announced an investment of 21 …
Aug 10, 2021DuPont Animal Nutrition to Partner with Proteon Pharmaceuticals in the Poultry IndustrySep 9, 2020
The partnership will bring the emerging bacteriophage technology to poultry producers, helping to mitigate antimicrobial resistance (PRWeb September 09, 2020) Read the full story at https://www.prweb.com/releases/dupont_animal_nutrition_to_partner_with_proteon_pharmaceuticals_in_the_poultry_industry/prweb17380913.htm
Sep 9, 2020Business Info
CIN ：U74999MH2017FTC303373
Registered State ：Maharashtra
Registrar Of Companies ：RoC-Mumbai
Category ：Company limited by Shares
Sub Category ：Subsidiary of Foreign Company
Company Class ：Private
Company Status ：Active
Registered Office Address ：Shop No. 9, C Wing, Rakhee vasant Utsav, Thakur Village, Kandivali (E) Mumbai Mumbai City MH IN 400101
Authorized Cap ：100000.00
Paidup Capital ：100000.00
Web Summary
Q1: What is the company name and its location?
A1: The company name is Vetphage Pharmaceuticals Private Ltd., but based on the provided content, it seems that the official website mentions Proteon Pharmaceuticals S.A. as a leading biotech company with its headquarters in Poland.
Q2: What products does the company offer for poultry farming?
A2: The company offers feed additives specifically designed to prevent and reduce the impact of bacterial infections in flocks caused by Salmonella, Avian Pathogenic E. coli (APEC), Aeromonas spp., and other pathogens. These products include BAFASAL, BAFACOL, and BAFASAL + G.
Q3: What is the focus of Proteon Pharmaceuticals' research and development?
A3: The company focuses on precision biology to modulate the microbiome, improving animal and human health while increasing environmental sustainability and eliminating the unnecessary use of antibiotics. They develop natural, safe, and environmentally sustainable products using their patented phageplatform technology.
Q4: Who is the founder and CEO of Proteon Pharmaceuticals?
A4: Prof. Jarosław Dastych, PhD, is the Founder, CEO, and Board President of Proteon Pharmaceuticals S.A., a leading biotech company with expertise in bacteriophage technology for livestock farming and aquaculture.
Q5: What is the mission and vision of Proteon Pharmaceuticals?
A5: The company's mission is to provide solutions that improve the economic efficiency of farms while promoting environmentally sound, natural, and sustainable practices. Their vision is to use precision biology to modulate the microbiome, improving animal and human health, increasing environmental sustainability, and eliminating the unnecessary use of antibiotics.
Q6: What is the role of Justyna Andrysiak in Proteon Pharmaceuticals?
A6: Justyna Andrysiak serves as the Chief Product & Technology Officer, combining a passion for biotechnology with expertise in phage technology. She has been instrumental in bridging the gap between scientific research and practical applications, fostering innovation, and partnerships.
Q7: What is Márcio Caparroz's role in Proteon Pharmaceuticals?
A7: Márcio Caparroz is the Chief Commercial Officer (CCO), responsible for shaping and implementing a commercial strategy that aligns with the company's vision and mission. He has over 20 years of international experience in Animal Nutrition and Health, focusing on meeting customers' unmet needs.
Q8: What sets Proteon Pharmaceuticals apart from other companies in the biotech industry?
A8: The company's unique bacteriophage platform technology offers sustainable solutions to bacterial disease management in animal farming, aquaculture, egg, and poultry production. This innovation has earned international recognition and various innovation awards, making Proteon Pharmaceuticals a leader in the field of phagebased products.
A1: The company name is Vetphage Pharmaceuticals Private Ltd., but based on the provided content, it seems that the official website mentions Proteon Pharmaceuticals S.A. as a leading biotech company with its headquarters in Poland.
Q2: What products does the company offer for poultry farming?
A2: The company offers feed additives specifically designed to prevent and reduce the impact of bacterial infections in flocks caused by Salmonella, Avian Pathogenic E. coli (APEC), Aeromonas spp., and other pathogens. These products include BAFASAL, BAFACOL, and BAFASAL + G.
Q3: What is the focus of Proteon Pharmaceuticals' research and development?
A3: The company focuses on precision biology to modulate the microbiome, improving animal and human health while increasing environmental sustainability and eliminating the unnecessary use of antibiotics. They develop natural, safe, and environmentally sustainable products using their patented phageplatform technology.
Q4: Who is the founder and CEO of Proteon Pharmaceuticals?
A4: Prof. Jarosław Dastych, PhD, is the Founder, CEO, and Board President of Proteon Pharmaceuticals S.A., a leading biotech company with expertise in bacteriophage technology for livestock farming and aquaculture.
Q5: What is the mission and vision of Proteon Pharmaceuticals?
A5: The company's mission is to provide solutions that improve the economic efficiency of farms while promoting environmentally sound, natural, and sustainable practices. Their vision is to use precision biology to modulate the microbiome, improving animal and human health, increasing environmental sustainability, and eliminating the unnecessary use of antibiotics.
Q6: What is the role of Justyna Andrysiak in Proteon Pharmaceuticals?
A6: Justyna Andrysiak serves as the Chief Product & Technology Officer, combining a passion for biotechnology with expertise in phage technology. She has been instrumental in bridging the gap between scientific research and practical applications, fostering innovation, and partnerships.
Q7: What is Márcio Caparroz's role in Proteon Pharmaceuticals?
A7: Márcio Caparroz is the Chief Commercial Officer (CCO), responsible for shaping and implementing a commercial strategy that aligns with the company's vision and mission. He has over 20 years of international experience in Animal Nutrition and Health, focusing on meeting customers' unmet needs.
Q8: What sets Proteon Pharmaceuticals apart from other companies in the biotech industry?
A8: The company's unique bacteriophage platform technology offers sustainable solutions to bacterial disease management in animal farming, aquaculture, egg, and poultry production. This innovation has earned international recognition and various innovation awards, making Proteon Pharmaceuticals a leader in the field of phagebased products.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
